MedPath
NMPA Approval

CICLESONIDE INHALATION AEROSOL

国药准字HJ20250036

covis pharma gmbhcovis pharma gmbh

April 1, 2025

Drug Information

环索奈德吸入气雾剂

气雾剂

每罐120揿,每揿含环索奈德200μg,递送剂量为160μg

化学药品

April 1, 2025

March 31, 2030

Company Information

Applicant Company

covis pharma gmbhcovis pharma gmbh

GRAFENAUWEG 12 ZUG,ZUG SWITZERLAND, 6300

Manufacturing Company

Derby Road Loughborough, United Kingdom, LE11 5SF

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

环索奈德吸入气雾剂 - NMPA 批准文号 | MedPath